Now Is A Suitable Moment For A Long-Term Purchase Of Procept BioRobotics Corp (NASDAQ: PRCT)
Currently, there are 50.47M common shares owned by the public and among those 48.24M shares have been available to trade. Insiders at the company have transacted a total of 27 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 14 of these insider trades were purchases, […]